Publication
Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial
Ofri Mosenzon, Thalia Marie Blicher, Signe Rosenlund, Jan W Eriksson, Simon Heller, Ole Holm Hels, Richard Pratley, Thozhukat Sathyapalan, Cyrus Desouza, R Abramof, D Alpenidze, S Aronoff, K Astamirova, B Barker, G Bedel, L Belousova, M Benson, I Beshay, W Biggs, K Blaze, P Bogdanski, R Busch, S Chaidarun, S Chandran, A Chang, S Chilka, A Cleland, L Connery, G Cornett, B Delgado, C Desouza, T Donner, K Eliasson, J Eriksson, S Folkerth, K Forshaw, H A Frandsen, E Frolova, W Gandy, G Gatipon, A Golovach, L Gonzalez-Orozco, J Gumprecht, E Haddad, T K Hansen, T Hart, S Hasan, B Hella, S Heller, M Hellgren, M Hewitt, S Hietaniemi, M Hitz, P Houser, R Huntley, R Jackson, P E Jakobsen, A Kapoor, L Kargina, E Kazakova, K Khan, E Klein, H Knoble, N Krasnopeeva (Kabachkova), A Krzeminski, M Kunitsyna, J Lawhead, K Levin, P Levin, L Lewy-Alterbaum, S Lindmark, R Lindsay, A Luts, T Lysenko, S Madsbad, T Maxwell, C Mbogua, J Mcknight, K Metsärinne, T Milovanova, E Morawski, O Mosenzon, D Nabriski, H Nguyen, P Nicol, S Nieminen, A Nikkola, P Norwood, P O'Donnell, A Odugbesan, J Parker, Y Pergaeva, A Peskov, S Plevin, J Pouzar, R Pratley, J Reed, P Rossing, T Sathyapalan, M Sergeeva-Kondrachenko, Z Shaikh, M Shamkhalova, N Shehadeh, Y Shlesinger, R Silver, B Snyder, J Soufer, J Strand, S Sulosaari, A Tirosh, H Traylor, N Uhlenius, G Vagapova, M Yanovskaya, L Zarutskaya, E Zhdanova
The Lancet Diabetes & Endocrinology, July 2019, Elsevier
DOI: 10.1016/s2213-8587(19)30192-5
